0001796909-19-000001.txt : 20191217
0001796909-19-000001.hdr.sgml : 20191217
20191217135235
ACCESSION NUMBER: 0001796909-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 504(b)(1) (not (i), (ii) or (iii))
ITEM INFORMATION: 06b
ITEM INFORMATION: 4a5
FILED AS OF DATE: 20191217
DATE AS OF CHANGE: 20191217
EFFECTIVENESS DATE: 20191217
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protego Biopharma
CENTRAL INDEX KEY: 0001796909
IRS NUMBER: 454187915
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-355671
FILM NUMBER: 191289211
BUSINESS ADDRESS:
STREET 1: 3210 MERRYFIELD ROW
STREET 2: JLABS
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585312187
MAIL ADDRESS:
STREET 1: 3210 MERRYFIELD ROW
STREET 2: JLABS
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001796909
Protego Biopharma
3210 MERRYFIELD ROW
JLABS
SAN DIEGO
CA
CALIFORNIA
92121
8585312187
DELAWARE
None
None
Corporation
true
XIN
JIANG
PROTEGO BIOPHARMA
3210 MERRYFIELD ROW
San diego
CA
CALIFORNIA
92121
Executive Officer
President & CEO
Richard
Labaudiniere
108 Fairbanks Oak Aly
Unit 401
Charleston
SC
SOUTH CAROLINA
29492
Director
Chairman of the Board of Directors
Jeffery
W
Kelly
10550 N. Torrey Pines Rd.
BCC-506
La Jolla
CA
CALIFORNIA
92037
Promoter
Scientific Co-founder
Edward
Hurwitz
2000 Sierra Point Parkway
Suite 701
Brisbane
CA
CALIFORNIA
94005
Director
Investor
Biotechnology
No Revenues
- 04
- 06b
- 4a5
false
2019-12-06
false
true
true
true
false
0
1000012
1000012
0
false
3
0
0
0
false
Protego Biopharma
XIN JIANG
XIN JIANG
President & CEO
2019-12-17